Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

Presentation TCT 2025

TCT 318: Stroke after TAVR - Impact on Clinical Outcome and Patient Reported Quality of Life (QoL): The Michigan Structural Heart Consortium (MISHC) Experience

Presenter: P. Michael Grossman

October 26, 2025

Presentation NY Valves 2025

Defining an Optimal Result of Transcatheter Tricuspid Valve Intervention: Results From the Tri-QOL Study

Presenter: Suzanne V. Arnold

June 26, 2025

Presentation TCT 2024

Japan Academic Perspective: The Patient’s View of QOL in Japan

Presenter: Koichiro Kinugawa

October 29, 2024

Presentation TCT 2023

Validation of the Kansas City Cardiomyopathy Questionnaire in Patients With Tricuspid Regurgitation: The Tri-QOL Study

Presenter: Suzanne Arnold

October 25, 2023

Presentation TCT 2018

PCI for Ischemia Part II: Why the ISCHEMIA Trial Might be Positive..or Negative!

Presenter: David J. Cohen, Sunil V. Rao, Ajay J. Kirtane

September 22, 2018

Presentation TCT 2018

PCI for Ischemia Part I: Critical Analysis of the FAME Trials and ORBITA

Presenter: David J. Cohen, Sunil V. Rao, Bernard J. Gersh

September 22, 2018

Presentation TCT 2018

Increasing Emphasis on QOL Outcomes: From Patient Preference to Instrument Validation

Presenter: David J. Cohen, Sunil V. Rao, John A. Spertus

September 22, 2018

Presentation TCT 2018

Optimal Medical Therapy With and Without Coronary Revascularization: Which Drugs Matter? Symptoms, Ischemia, or Prognosis? And Magnitude of Impact

Presenter: David J. Cohen, Sunil V. Rao, David J. Maron

September 22, 2018

Presentation TCTAP 2018

DECISION-CTO: Updated QOL and Long-Term Outcomes

Presenter: Seung-Whan Lee

April 28, 2018

Presentation TCT 2017

Topic 3: Chronic Total Occlusion PCI - What Level of Evidence Is Required for Widespread Acceptance: Hard Endpoints vs QOL Measures

Presenter: Robert A. Byrne, Gregg W. Stone, J. Aaron Grantham

October 30, 2017

Presentation TCT 2017

EXCEL QOL: Quality of Life After PCI vs CABG in Left Main Coronary Artery Disease

Presenter: Gregg W. Stone, Suzanne J. Baron

October 30, 2017

Presentation

Relationship Between Stent Type and QoL Following PCI for Acute MI

Presenter: Adnan K. Chhatriwalla

July 30, 2015

Presentation

Temporal Trends in QoL Outcomes After Transapical TAVR: PARTNER Substudy

Presenter: H. Gada

June 12, 2015

Presentation

Comparison of QoL Measures After Radial vs Femoral Artery Access for Cardiac Cath in Women

Presenter: Connie N. Hess

May 14, 2015

Presentation

Neurologic Function and Health-Related QoLFollowing Targeted Temperature Management at 33ºC vs 36ºC After Out-of-Hospital Cardiac Arrest

Presenter: T. Cronberg

April 10, 2015

Presentation

IRONIC: Improved QoL After 1 Year with Invasive vs Noninvasive Strategy in Claudicants

Presenter: Joakim Nordanstig

August 13, 2014

Presentation

Improved Functional Status and QoL in Prohibitive Surgical Risk Patients with Degenerative Mitral Regurgitation After Transcatheter Mitral Valve Repair

Presenter: D.S. Lim

July 07, 2014

Presentation TVT 2014

The TAVR Economic Value Proposition The Impact of Valve Costs, Complications, QOL Benefits, and Reimbursement Strategies

Presenter: David J. Cohen

June 07, 2014

Presentation

Health-Related QOL After Transcatheter or Surgical Aortic Valve Replacement in High-Risk Pts with Severe Stenosis

Presenter: M. R. Reynolds

July 18, 2012

Presentation

Serial Change in Health-Related QOL Over 1 Year After TAVR: Predictors of Health Outcomes

Presenter: T. A. Fairbairn

April 30, 2012

Advertisement

TCT 318: Stroke after TAVR - Impact on Clinical Outcome and Patient Reported Quality of Life (QoL): The Michigan Structural Heart Consortium (MISHC) Experience

Defining an Optimal Result of Transcatheter Tricuspid Valve Intervention: Results From the Tri-QOL Study

Japan Academic Perspective: The Patient’s View of QOL in Japan

Validation of the Kansas City Cardiomyopathy Questionnaire in Patients With Tricuspid Regurgitation: The Tri-QOL Study

PCI for Ischemia Part II: Why the ISCHEMIA Trial Might be Positive..or Negative!

PCI for Ischemia Part I: Critical Analysis of the FAME Trials and ORBITA

Increasing Emphasis on QOL Outcomes: From Patient Preference to Instrument Validation

Optimal Medical Therapy With and Without Coronary Revascularization: Which Drugs Matter? Symptoms, Ischemia, or Prognosis? And Magnitude of Impact

DECISION-CTO: Updated QOL and Long-Term Outcomes

Topic 3: Chronic Total Occlusion PCI - What Level of Evidence Is Required for Widespread Acceptance: Hard Endpoints vs QOL Measures

EXCEL QOL: Quality of Life After PCI vs CABG in Left Main Coronary Artery Disease

Relationship Between Stent Type and QoL Following PCI for Acute MI

Temporal Trends in QoL Outcomes After Transapical TAVR: PARTNER Substudy

Comparison of QoL Measures After Radial vs Femoral Artery Access for Cardiac Cath in Women

Neurologic Function and Health-Related QoLFollowing Targeted Temperature Management at 33ºC vs 36ºC After Out-of-Hospital Cardiac Arrest

IRONIC: Improved QoL After 1 Year with Invasive vs Noninvasive Strategy in Claudicants

Improved Functional Status and QoL in Prohibitive Surgical Risk Patients with Degenerative Mitral Regurgitation After Transcatheter Mitral Valve Repair

The TAVR Economic Value Proposition The Impact of Valve Costs, Complications, QOL Benefits, and Reimbursement Strategies

Health-Related QOL After Transcatheter or Surgical Aortic Valve Replacement in High-Risk Pts with Severe Stenosis

Serial Change in Health-Related QOL Over 1 Year After TAVR: Predictors of Health Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content